1. Home
  2. ARVN vs MCFT Comparison

ARVN vs MCFT Comparison

Compare ARVN & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.04

Market Cap

658.2M

Sector

Health Care

ML Signal

HOLD

Logo MasterCraft Boat Holdings Inc.

MCFT

MasterCraft Boat Holdings Inc.

HOLD

Current Price

$25.57

Market Cap

604.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARVN
MCFT
Founded
2015
1968
Country
United States
United States
Employees
N/A
700
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
658.2M
604.0M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
ARVN
MCFT
Price
$8.04
$25.57
Analyst Decision
Buy
Hold
Analyst Count
19
5
Target Price
$15.05
$24.25
AVG Volume (30 Days)
680.3K
117.2K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
58.84
N/A
EPS
N/A
0.33
Revenue
$262,600,000.00
$284,203,000.00
Revenue This Year
N/A
$9.18
Revenue Next Year
N/A
$8.23
P/E Ratio
N/A
$75.56
Revenue Growth
N/A
N/A
52 Week Low
$6.06
$17.19
52 Week High
$14.22
$28.44

Technical Indicators

Market Signals
Indicator
ARVN
MCFT
Relative Strength Index (RSI) 46.65 65.68
Support Level $7.35 $21.90
Resistance Level $10.18 $26.49
Average True Range (ATR) 0.41 0.93
MACD 0.17 0.30
Stochastic Oscillator 70.20 97.32

Price Performance

Historical Comparison
ARVN
MCFT

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About MCFT MasterCraft Boat Holdings Inc.

MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.

Share on Social Networks: